Peninsula Energy Ltd
- Country
- Ownership
- -
- Employees
- 4.2K
- Market Cap
- -
- Introduction
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Clinical Trials
33
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).
- Conditions
- Acute Ischemic Stroke (AIS)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Penumbra Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT07107022
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
- Conditions
- Lower Extremity Acute Limb IschemiaLE ALI
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Penumbra Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06747117
- Locations
- 🇺🇸
Christiana Care Health Services, Inc., Newark, Delaware, United States
🇺🇸Radiology and Imaging Specialists, Lakeland, Florida, United States
🇺🇸TriHealth Good Samaritan Hospital, Cincinnati, Ohio, United States
Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
- Conditions
- Arterial Occlusion Mesenteric Artery SuperiorAcute Limb IschemiaAcute DVT of Lower Extremity
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Penumbra Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT06446024
- Locations
- 🇯🇵
Nara City Hospital, Nara, Japan
Comparison of Two Pulmonary Embolism Treatments
- Conditions
- Pulmonary Embolism Acute
- Interventions
- Drug: AnticoagulationDevice: mechanical aspiration thrombectomy
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Penumbra Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05684796
- Locations
- 🇺🇸
Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, Georgia, United States
🇺🇸St. Elizabeth Edgewood Hospital, Edgewood, Kentucky, United States
🇺🇸The University of Arizona - Banner, Tucson, Arizona, United States
THUNDER: Acute Ischemic Stroke Study With the Penumbra System® Including Thunderbolt™ Aspiration Tubing
- Conditions
- Large Vessel OcclusionAcute Ischemic Stroke
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Penumbra Inc.
- Target Recruit Count
- 216
- Registration Number
- NCT05437055
- Locations
- 🇺🇸
Abrazo West Campus, Goodyear, Arizona, United States
🇺🇸Sharp Grossmont, San Diego, California, United States
🇺🇸HRI - Swedish, Englewood, Colorado, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
Penumbra Completes Enrollment in Landmark STORM-PE Trial Testing Thrombectomy for Pulmonary Embolism
Penumbra has completed enrollment of 100 patients in the pivotal STORM-PE randomized controlled trial, comparing computer assisted vacuum thrombectomy plus anticoagulation versus anticoagulation alone for acute intermediate-high risk pulmonary embolism.
Penumbra Launches Ruby XL System, the Largest Embolization Coil Platform for Vascular Procedures
Penumbra received FDA clearance for the Ruby XL System, featuring the longest, largest, and softest embolization coils commercially available for vascular procedures.
Penumbra Completes Enrollment in THUNDER Study for Acute Ischemic Stroke
Penumbra, Inc. has completed enrollment in its THUNDER clinical study, evaluating the Penumbra System with Thunderbolt Aspiration Tubing for acute ischemic stroke.